Evidence map›Paper›PMID 39035420›Full record

ArticleBrain communications2024

Associations of amyloid-β oligomers and plaques with neuropathology in the

Jiabin Tang, Helen Huang, Robert C J Muirhead, Yue Zhou, Junheng Li, John DeFelice, Maksym V Kopanitsa, Lutgarde Serneels, Karen Davey, Bension S Tilley and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Reduction in hippocampal cholinergic neurostimulating peptide enhances memory impairment in AppAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiabin TangUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.
Helen HuangDepartment of Metabolism, Digestion and Reproduction, Imperial College London, South Kensington Campus, London SW7 2AZ, UK.
Robert C J MuirheadUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.
Yue ZhouDepartment of Mechanical Engineering, Roberts Engineering Building, University College London, London WC1E 7JE, UK.
Junheng LiUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.ORCID https://orcid.org/0000-0002-6210-5997
John DeFeliceDepartment of Brain Sciences, Burlington Danes Building, Imperial College London, Hammersmith Campus, London W12 0NN, UK.
Maksym V KopanitsaUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.
Lutgarde SerneelsCentre for Brain and Disease Research, Flanders Institute for Biotechnology (VIB), 9052 Gent, Belgium.
Karen DaveyUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.
Bension S TilleyDepartment of Brain Sciences, Burlington Danes Building, Imperial College London, Hammersmith Campus, London W12 0NN, UK.
Steve GentlemanDepartment of Brain Sciences, Burlington Danes Building, Imperial College London, Hammersmith Campus, London W12 0NN, UK.
Paul M MatthewsUK Dementia Research Institute, Uren Building, Imperial College London, White City Campus, London W12 0BZ, UK.ORCID https://orcid.org/0000-0002-1619-8328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid-β pathology and neurofibrillary tangles lead to glial activation and neurodegeneration in Alzheimer's disease. In this study, we investigated the relationships between the levels of amyloid-β oligomers, amyloid-β plaques, glial activation and markers related to neurodegeneration in the

Indexed as

amyloid-βAppNL-G-Fimaging mass cytometryneuropathologyoligomers

Identifiers

PMID39035420
PMCPMC11258573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.